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ABSTRACT
Introduction Irish healthcare has undergone
extensive change recently with spending cuts
and a focus on quality initiatives; however, little
is known about adverse event occurrence.
Objective To assess the frequency and nature of
adverse events in Irish hospitals.
Methods 1574 (53% women, mean age
54 years) randomly selected adult inpatient
admissions from a sample of eight hospitals,
stratified by region and size, across the Republic
of Ireland in 2009 were reviewed using two-
stage (nurse review of patient charts, followed by
physician review of triggered charts) retrospective
chart review with electronic data capture. Results
were weighted to reflect the sampling strategy.
The impact on adverse event rate of differing
application of international adverse event criteria
was also examined.
Results 45% of charts were triggered. The
prevalence of adverse events in admissions was
12.2% (95% CI 9.5% to 15.5%), with an
incidence of 10.3 events per 100 admissions
(95% CI 7.5 to 13.1). Over 70% of events were
considered preventable. Two-thirds were rated as
having a mild-to-moderate impact on the
patient, 9.9% causing permanent impairment
and 6.7% contributing to death. A mean of 6.1
added bed days was attributed to events,
representing an expenditure of €5550 per event.
The adverse event rate varied substantially
(8.6%–17.0%) when applying different
published adverse event eligibility criteria.
Conclusions This first study of adverse events in
Ireland reports similar rates to other countries. In
a time of austerity, adverse events in adult
inpatients were estimated to cost over €194
million. These results provide important baseline
data on the adverse event burden and, alongside
web-based chart review, provide an incentive
and methodology to monitor future patient-
safety initiatives.
INTRODUCTION
Preventable adverse events are an
ongoing challenge in healthcare.
International studies demonstrate that
3%–17% of admissions are associated
with an adverse event (defined as an
injury caused by healthcare management
resulting in prolonged hospitalisation,
disability on discharge or death1).2 3
Approximately half of the adverse events
are preventable.4
Little is known about adverse events in
the Irish healthcare system.
Notwithstanding a number of reports
into individual incidents,5 6 there is no
comprehensive national collection of
adverse event data, and voluntary report-
ing captures only a small proportion of
events.7 Therefore, recommendations on
improving patient safety at a national
level are being made on limited informa-
tion. Additionally, the WHO recom-
mends collecting local data to provide the
mandate and commitment for national
patient-safety action.8
The aim of the Irish National Adverse
Events Study (INAES) was to quantify
the frequency and nature of adverse
events in acute hospitals in the Republic
of Ireland for the first time using an
internationally recognised retrospective
patient chart review methodology.
Previous studies have shown a fivefold
difference in adverse event frequency, but
these differences are difficult to interpret
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due to variation in inclusion criteria for eligible
events. We therefore also wished to examine how the
Irish rate would vary with application of different
published adverse event criteria.3 9 10
Patient data from 2009 were collected as it predated
the establishment of the National Clinical
Programmes in Ireland in 2010: the programmes aim
to improve and standardise the quality of patient
care.11 INAES was therefore designed to assess the
baseline burden of adverse events and enable future
evaluation of the effect of these programmes on
patient safety. The INAES also employed web-based
electronic data capture which has the potential to
make the methodology more accessible for organisa-
tions to assess and monitor their patient-safety
initiatives.
METHODS
To allow international comparison, we based our
methods on the Canadian Adverse Events Study
which employed a modified protocol of the Harvard
Medical Practice Study.1 12 Similar protocols have
been used in other international adverse event
studies.2–4 9 13–26 This involves a two-stage review of
patient charts with nurse reviewers screening for trig-
gers that may identify an adverse event (stage 1), fol-
lowed by physician reviewers determining the
presence of adverse event(s) in trigger positive charts
(stage 2).
Definitions
An adverse event was defined as an unintended injury
or complication resulting in disability at the time of
discharge, prolonged hospital stay or death and that
was caused by healthcare management rather than by
the underlying disease process.1 Disability was
restricted to temporary (lasting up to a year) or per-
manent impairment of physical function.12 Healthcare
management included the actions of individual hos-
pital staff as well as the broader systems and care pro-
cesses of healthcare, including both acts of omission
(failure to diagnose or treat or manage) and acts of
commission (incorrect diagnosis or treatment).12
Study sample
The study hospitals were all acute public hospitals in
the Republic of Ireland—public hospitals provide
approximately 88% of the national acute hospital
beds.27 Thirty hospitals listed in the Irish Health
Service Executive (HSE) 2012 hospital Casemix
annual budget adjustment were invited to participate
(this excluded eight hospitals with a sole clinical spe-
cialty focus, ie paediatrics, maternity and orthopae-
dics).28 Casemix is a system which groups patient data
to compare activity and costs between hospitals.29
Hospitals were classified as ‘large’ if total annual
inpatient, day case and emergency department
Casemix units were over 100 000 and/or the hospital
hosted a National Cancer Centre (ie, where staff with
specialist cancer expertise are concentrated30); with
the remainder classified as ‘small’. The approximate
number of annual Casemix units (and distribution
into inpatient/day case/emergency) for the nine large
hospitals was 980 000 (22%/37%/41%), and for the
21 small, it was 860 000 (30%/23%/47%).28 Eighteen
hospitals agreed to participate, six refused and six did
not reply despite several contacts. The selection
process involved random sampling of participating
hospitals, stratified by health system (HSE) region and
hospital size, to select eight hospitals: one ‘large’ and
one ‘small’ from each of the four regions.31
After hospital selection, a random sample of 300–
400 admissions (‘index admissions’) for the calendar
year 2009 was generated at each site using the hospi-
tal’s local Hospital Inpatient Enquiry (HIPE) elec-
tronic discharge database. HIPE collects demographic,
clinical and administrative information on discharges
and deaths from acute hospitals in the Republic of
Ireland. Discharge diagnoses and procedures are
coded using ICD-10 AM/ACHI/ACS 6th edition
(International Classification of Diseases 10th revision
Australian Modification/Australian Classification
Health Interventions/Australian Coding Standards).32
The sampling frame included all inpatient admis-
sions for patients aged at least 18 years who had a
minimum stay in hospital of 24 h (or died within
24 h) and excluded admissions with a principal diag-
nosis related to obstetrics or psychiatry (ICD-10 codes
F00–F99 and O29–O92733). Admissions that were
recorded in HIPE as being a transfer from another
hospital were excluded as the likelihood was that full
clinical information from the transferring hospital
would not be available. Nurse reviewers conducted a
further eligibility check prior to commencing review
of each chart to identify ineligible admissions that
were not able to be excluded using our HIPE method-
ology, that is, inpatients who were discharged within
24 h and obstetric admissions resulting in uncompli-
cated births with non-obstetric principal diagnosis
codes. Early pregnancy (<20 weeks) was included in
line with the Canadian Adverse Events Study.12
Reviewer training
Six nurse reviewers, each with a minimum of 7 years’
nursing experience and all having experience in clin-
ical research, audit, hospital management and/or edu-
cation and three physician reviewers (two recently
retired respiratory physicians and one public health
medicine physician) performed the chart reviews.
Researchers from the Canadian adult and paediatric
adverse events studies conducted face-to-face training
of the reviewer group over 2½ days.12 17 An opera-
tions manual containing the study protocol and
instructions for the web-based data collection was
adapted from the Canadian manual. The Canadian
website data entry forms and database were modified
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for the Irish healthcare setting. The web-based data
collection tool captured all study data. It had several
advantages—prepopulation of admission demographic
data, streamlined data entry (compulsory fields,
review of each injury with automatic adverse event
determination if the definition was satisfied),
enhanced data security (direct download to a secure
server), central monitoring of site progress, automatic
assignment of reliability charts and direct transfer into
statistical software. Structured implicit review assisted
physician reviewers to assess causation and prevent-
ability with the tool guiding reviewers through a series
of questions before they made their judgements.
Reviewers independently reviewed 20 training
charts immediately following the group training.
These were assessed for inter-rater reliability by calcu-
lating the κ statistic (nurse κ=0.16, physician
κ=0.52). The low κ for the nurses was due to a
subset of nurses being oversensitive and triggering
nearly all of the charts. The training charts were dis-
cussed in the reviewer groups before beginning data
collection. The nurses had support on their initial 10
study charts. A 10% sample of patient charts was rere-
viewed by all nurse or physician reviewers at each site.
The κ statistics in the field improved to nurses 0.79
(95% CI 0.68 to 0.88) and physicians 0.59 (95% CI
0.37 to 0.79).
A sample of trigger-negative charts at each site was
also reviewed by a physician reviewer for adverse
events as part of a sensitivity analysis of the stage 1
trigger methodology. The sensitivity and specificity
were calculated as 96% and 64% respectively, with a
1.0% (95% CI 0.1% to 3.7%) prevalence of adverse
events in missed charts (2/196 trigger-negative charts
contained events).
Data collection
Patient charts were reviewed between December 2013
and January 2015. Stage 1 involved nurse review of
each chart using a list of 18 ‘triggers’ (eg, unplanned
readmission, hospital-acquired infection, adverse drug
reaction; online supplementary appendix 1). Chart
reviews centred on the index admission and all docu-
mentation 1 year before and after. The majority of
patient charts were paper based or scanned paper
records. In some sites, reports or correspondence
were available electronically but these tended to dupli-
cate documents included in the paper chart. There
was no limit on time taken to review charts.
Stage 2 involved physician review of triggered
charts to determine whether an adverse event had
occurred. One physician reviewed each chart. Adverse
events, which occurred within 12 months before, or
during, the index admission, which were detected
either during the index admission or within
12 months afterwards, were included. The physician
reviewer rated the impact of the event, the likelihood
that it was caused by healthcare management and its
degree of preventability using standard scales (see
online supplementary appendix 2). For each event,
the physician classified its nature (ie, whether it was
related to diagnosis or other clinical management, an
operation or non-surgical procedure, a fracture, an
anaesthetic, administration of fluids or medication,
pregnancy and/or another type of event) and whether
a system issue was involved (ie, if failures within the
healthcare system contributed to the event). A consult-
ant surgeon was available for advice on surgical cases.
Demographic and administrative data on the index
admissions (age, sex, discharge diagnoses and proce-
dures, consultant specialty code, admission and dis-
charge dates) were collected at the time of random
selection at each site. National demographic data for
equivalent adult inpatients in acute public hospitals
during 2009 was provided by the Healthcare Pricing
Office and generated using the same HIPE search
strategy as employed in the INAES sampling (see
online supplementary appendix 3).34
Analysis
Power calculation
A sample size of 1500 admissions was calculated using
a 20% rate of adverse events and ±2% precision
(with precision improving at lower rates).3 This
allowed a precision of ±5% in any subgroup consti-
tuting 20% or more of the total sample. Thus, at least
187 eligible admissions were required to be reviewed
at each hospital.
Weighting and analyses
The risk (period prevalence) of adverse events in
inpatient hospital admissions was calculated as the
proportion of admissions associated with one or more
adverse events.12 The incidence density was calculated
as the number of adverse events occurring per 100
admissions, excluding events occurring prior to the
index admission (to avoid double counting). CIs for
binary variables were modelled using logistic regres-
sion; CIs for incidence were calculated using Poisson
regression with robust variance estimation to account
for overdispersion; p values were derived from logistic
regression, unless otherwise noted. To maximise the
number of adverse events reviewed, the sample was
stratified such that half of admissions had undergone
a surgical procedure (without stratification, this figure
was approximately one quarter34). The procedure
codes for general anaesthetic, regional and neuroaxial
blocks (ACHI 9251400–9251499, 9250800–
9251299) were used as proxies to indicate that
surgery was likely to have been performed during the
admission. Analyses were weighted for this sampling
frame (ie, the ratio of admissions with and without
the anaesthetic procedure codes in each hospital’s eli-
gible study population). Inter-rater reviewer reliability
was analysed using Cohen’s κ, with CIs calculated
using a bootstrap method implemented in the user-
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written command kapci.35 All analyses were per-
formed using Stata release 13.1.
The national cost of adverse events in adult inpati-
ents was estimated as the product of (1) the estimated
number of adverse events—using the INAES incidence
density of adverse events applied to the number of
adult inpatient admissions to acute public hospitals in
2009, excluding those with obstetric and psychiatric
principal diagnoses (n=339,84434); and (2) the
average cost of an event—calculated as the INAES
mean number of added bed days attributed to adverse
events multiplied by the average cost of an inpatient
hospital bed in Ireland in 2009 (€909 per day36).
RESULTS
A total of 2600 admissions were randomly selected
from the hospitals’ HIPE discharge databases.
Oversampling was performed to account for missing
charts or ineligible admissions. Hospitals were advised
to retrieve charts in batches from the top of the ran-
domly generated list. Nurse reviewers were asked to
review a target of 190–200 eligible charts at each site,
reviewing the top 200 charts first and using the over-
sample as backup. A total of 1854 charts were
screened for eligibility by the nurse reviewers and
1609 (87%) were eligible for the study (figure 1). The
majority of ineligible admissions had a hospital stay of
under 24 h. After excluding charts with inadequate
documentation, 1580 admissions underwent a full
stage-1 review (188–201 admissions per hospital), of
which 6 were excluded by physician reviewers leaving
a total of 1574 fully reviewed charts (figure 1).
The reviewed charts were comparable with national
acute public hospital admissions in 2009 for age, sex
and length of stay (see online supplementary
appendix 3). However, a lower proportion of the
national admissions compared with the INAES sample
died during the admission (2.7% vs 4.8%, respectively).
This is likely due to INAES excluding admissions with a
hospital stay under 24 h unless the patient died, whereas
the national figure includes all short-duration
admissions.
A total of 45% of charts reviewed in stage 1 were
trigger positive. The triggers of hospital-acquired
infection, unplanned return to the operating theatre
and unplanned removal/injury during surgery had the
highest relative risks for subsequent adverse event
determination (5.3, 4.8, 4.7, respectively; online sup-
plementary appendix 1).
In stage 2, physician reviewers identified 247
adverse events in 211 admissions, including 15% with
more than one event (see case descriptions in online
supplementary appendix 4). Most (72.4%, weighted)
of the adverse events occurred during the index
admission (table 1). Approximately a quarter of events
(23.5%) were detected after the index admission, and
in 27.7%, the event occurred prior to the index
admission.
The overall adverse event prevalence (ie, the pro-
portion of admissions associated with one or more
adverse events) was 12.2% (95% CI 9.5% to 15.5%)
after weighting for the sample frame. The weighted
incidence density was 10.3 adverse events per 100
admissions (95% Poisson CI 7.5 to 13.1). The mean
age of patients was significantly higher among admis-
sions with an adverse event than those without
(61.8 years vs 55.4 years; p<0.001 (t test)), and with
each 10-year age increment, there was an 18%
increase in risk of an adverse event (OR 1.18, 95% CI
1.09 to 1.27). There was no difference in risk
between women and men (p=0.683).
Of the 247 adverse events, 179 (72.5%) were
judged to be preventable (see online supplementary
appendix 2). When these results were adjusted for the
sampling strategy, 72.7% (95% CI 58.8% to 83.3%)
of events were deemed preventable (table 2), includ-
ing 74.6% (95% CI 60.2% to 85.1%) of the 187
events occurring during the index admission. There
was no difference between large and small hospitals in
risk of an adverse event (p=0.918) or in the propor-
tion rated as preventable (p=0.254).
Two-thirds (67.6%, weighted) of adverse events
resulted in no physical impairment or disability at dis-
charge or in minimal-to-moderate impairment with
recovery within 6 months (see online supplementary
appendix 2). Nonetheless, 9.9% of the adverse events
resulted in permanent disability, and 6.7% (occurring
in 14 patients) were judged to have contributed to the
Figure 1 Flow chart of the INAES chart review process. INAES,
Irish National Adverse Events Study. *<24 hours (n=216),
uncomplicated birth (n=25), transfer (n=2), not admitted (n=1),
under 18 years old (n=1). †<24 hours (n=1), uncomplicated
birth (n=1), transfer (n=3), unable to locate (n=1).
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patient’s death (see online supplementary appendix 2).
There was no significant difference in risk of death in
admissions that had adverse events compared with
admissions without events (p=0.331).
Patients who experienced adverse events had a
median length of index admission of 7 days (IQR 3,
17) compared with four days (IQR 2, 8) without
adverse events (p<0.001, Wilcoxon–Mann–Whitney).
Physician reviewers judged events occurring in the
index admission to result in a mean of 6.1 (95% CI 4.8
to 7.7) additional hospital days in that admission or
readmission(s). This represents an additional cost of
approximately €5550 for each adverse-event-associated
admission, which when extrapolated nationally gives
an estimated annual cost of hospital-based adverse
events to the Irish healthcare system of €194 million.
Adverse event risk was higher in admissions with
anaesthetic procedure codes indicating a surgical pro-
cedure was likely to have occurred, than in admissions
without these codes (17.9% (95% CI 13.5% to
22.3%) versus 10.2% (95% CI 7.2% to 13.1%)).
However, when the 1499 admissions with medical or
surgical consultant speciality codes were compared,
there was no difference in event frequency between
the specialities: medical-weighted prevalence 11.9%
(95% CI 8.3% to 15.5%), surgical 13.1% (95% CI
9.8% to 16.5%). The type of adverse event varied by
speciality, with surgical specialities having a greater
proportion of operation-related events (occurring
during surgery or within 30 days postoperatively),
whereas therapeutic events (inappropriate or delay in
treatment or failure to monitor) and medication-
related events were the dominant categories for
medical specialities (figure 2). When operation-related
events were removed, the distribution of remaining
event types was similar in medical and surgical special-
ties (see online supplementary appendix 5). A system
issue was identified in 106 events (weighted propor-
tion 46.1% (95% CI 31.5% to 61.4%)). Overall,
adverse events resulting from errors of omission were
as common as those resulting from errors of commis-
sion (data not shown), with no significant difference
between medical and surgical specialties (p=0.627).
Adverse event prevalence varied significantly if
different criteria were used to identify the events
(table 3). For example, exclusion of events occurring
in the index admission and discovered subsequently
reduced the weighted risk to 9.4% (95% CI 7.4% to
11.9%).1 9 Similarly exclusion of events prior to the
index admission resulted in a risk of 8.6% (95% CI
6.7% to 10.9%).19 If events caused by healthcare
management outside the index hospital were included
(eg, occurring in general practice, nursing homes or
other healthcare facilities), then the weighted preva-
lence rose to 14.6% (95% CI 11.6% to 18.3%).22
Furthermore, using a lower threshold to determine
likelihood of causation by healthcare management (a
score of ≥2, online supplementary appendix 2)
increased the prevalence to 14.5% (95% CI 11.3% to
18.4%),21 and if events caused by healthcare
Table 1 The weighted distribution of adverse events by the timing of occurrence and detection
Timing of adverse event occurrence (O) and detection (D)
Weighted distribution (95% CI) of all study adverse events* Before index admission Index admission After index admission
48.9% (40.7% to 57.0%) O D
27.7% (19.9% to 37.0%) O D
23.5% (18.1% to 29.9%) O D
*Point estimates and CIs were weighted to account for the sampling frame.
Table 2 Adverse event frequency, by hospital type
Hospital type
Variable Small Large All
Number of admissions sampled 792 782 1574
Number of admissions associated with an adverse event 108 103 211
Crude adverse event prevalence (95% CI) 13.6% (11.4% to 16.2%) 13.2% (11.0% to 15.7%) 13.4% (11.8% to 15.2%)
Weighted adverse event prevalence (95% CI)* 12.4% (7.7% to 17.1%) 12.1% (8.5% to 15.7%) 12.2% (9.5% to 15.5%)
Number of adverse events 123 124 247
Number of incident adverse events (ie, excluding events
occurring prior to the index admission)
89 98 187
Crude incidence of adverse events per 100 admissions (95% CI) 11.2 (9.0 to 13.8) 12.5 (10.2 to 15.3) 11.9 (10.2 to 13.7)
Weighted incidence of adverse events per 100 admissions (95% CI)* 9.5 (7.0 to 11.9) 10.8 (6.0 to 15.6) 10.3 (7.5 to 13.1)
Weighted percentage of adverse events that were
preventable (95% CI)*
80.1% (68.7% to 91.5%) 68.1% (52.4% to 83.9%) 72.7% (58.8% to 83.3%)
*Point estimates and CIs were weighted to account for the sampling frame.
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management outside the index hospital were also
included, this became 17.0% (95% CI 13.4% to
21.3%).3
DISCUSSION
This is the first national study to report adverse event
prevalence in the Republic of Ireland. The major
strengths of this research are its standardised method-
ology and the ability to compare with international
studies that have used this method but different
adverse event eligibility criteria. Our adverse event
prevalence of 12.2% and incidence of 10.3 events per
100 admissions fall at the upper end of the range of
other international studies (3%–17%).3 9 At a national
level, this extrapolates to 41 000 admissions asso-
ciated with one or more adverse events out of
approximately 340 000 similar admissions to Irish
acute public hospitals in 2009.
In contrast, adverse events were reported in only
1.9% of patient contacts in 2011 to the National
Incident Management System (NIMS).37 38 While not
directly comparable (NIMS includes near-misses and
community settings), there appears to be significant
under-reporting of adverse events in the Irish health-
care system, similar to other research.7 23 Reasons for
this include lack of awareness or belief in the value of
reporting, fear of litigation and lack of a supportive
culture encouraging reporting.39 40
The leading categories of events by frequency in
INAES were similar to other studies: operation related,
therapeutic, medication related and diagnostic.9 12 13
Additional analyses will be needed to delineate the
nature of events within these categories for prioritisa-
tion of future patient-safety initiatives. Unlike the
Canadian study, we did not find a difference with hos-
pital size; however, hospital categorisation differs
between studies and necessarily relates to local demo-
graphic and health service factors.12 Over 70% of
INAES adverse events were considered preventable.
This appears high (compared with a previous system-
atic review aggregate estimate of 43.5%4) but prevent-
ability is likely to increase over time with advances in
surgical techniques, therapeutics, quality initiatives and
increased availability of documentation with electronic
clinical notes;41 more recent studies have reported
similar rates.16 18 22 Furthermore, judgement of pre-
ventability can only be based on available documenta-
tion and will be influenced by reviewers’ experience
and knowledge.42 43 In line with other research, under-
going a surgical procedure was associated with a
greater risk of an adverse event.4 However, this finding
was not true for the surgical specialities overall. This is
probably because a quarter of admissions coded with a
Figure 2 Frequency of adverse event types for medical and
surgical specialties.
Table 3 Weighted occurrence of Irish National Adverse Events Study (INAES) adverse events with the application of international adverse
event eligibility criteria
Adverse event eligibility criteria
Weighted prevalence
(95% CI)
Weighted incidence
density (95% CI)
Magnitude (%)
change in
prevalence
Include only events related to the index hospital (exclude events
caused by healthcare management outside the index hospital) with
healthcare management causation at least more likely (≥4 out of 6,
online supplementary appendix 2). INAES prevalence
12.2% (9.5% to 15.5%) N/A* Baseline
Exclude adverse events detected after the index admission 9.4% (7.4% to 11.9%) 10.9 events per 100
admissions (8.2 to 13.7)
23% decrease
Exclude adverse events occurring prior to the index admission.
INAES incidence
8.6% (6.7% to 10.9%) 10.3 events per 100
admissions (7.5 to 13.1)
30% decrease
Include adverse events in all settings (ie, include events caused by
healthcare management outside the index hospital)
14.6% (11.6% to 18.3%) N/A* 20% increase
Include events with at least slight-to-moderate evidence for
healthcare management causation (≥2 out of 6, online
supplementary appendix 2)
14.5% (11.3% to 18.4%) N/A* 19% increase
Include all events with at least slight-to-moderate evidence for
healthcare management causation (≥2 out of 6, online
supplementary appendix 2) in all settings
17.0% (13.4% to 21.3%) N/A* 39% increase
*Not applicable: unable to calculate an incidence because including events occurring in admissions prior to the index admission as well as events detected
in subsequent admissions will result in double counting.
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surgical speciality (ie, under the care of a surgical con-
sultant for their principal diagnosis) did not appear to
have had surgery ( judged by the absence of a proced-
ure code for an anaesthetic) while approximately 5%
of those with a medical code underwent surgery.
Comparison of published adverse event rates is prob-
lematic. Results from international studies conducted
over a 30-year period present the burden of adverse
events at one point in time and may not reflect current
practices or quality and patient-safety improvements in
that healthcare system. In addition to differences in
setting, these studies differed by eligible population,
threshold for causation by healthcare management,
extent of documentation reviewed and the timing and
location of events relative to the index admission. For
example, some studies included paediatric and all
obstetric patients and had no length-of-stay eligibility
criteria,1 9 13 some had a lower threshold for caus-
ation,3 while others did not include events that were
discovered before, or after, the index admission.1 9 19
When our data were recalculated by applying different
adverse event criteria, the INAES prevalence varied
from 8.6% to 17.0% (representing a 30% decrease to a
40% increase when compared with the main result of
12.2%). This highlights the challenges inherent in
measuring and comparing adverse events. Current
variation in methodology and definitions, as well as
setting and year, make it difficult to assess whether
there are intrinsic differences in adverse event occur-
rence between healthcare systems.44
The cost of adverse events is significant in terms of
adverse outcomes for patients and the trauma and
consequences for all involved—patients, families and
staff.45 Financially, an annual cost of €194 million
represents approximately 4% of the Irish healthcare
acute services 2009 budget.46 This is an underestimate
as it does not take into account costs such as escal-
ation of care and litigation. Furthermore, day cases,
emergency department assessments, paediatric and the
majority of obstetric and psychiatric admissions were
not included in our study.
Study limitations
Not all invited hospitals agreed to participate.
However, the INAES included large and small hospi-
tals from across the country and was comparable with
national demographic data. Our estimate may not
have captured all adverse events. For example, the
two-stage methodology means that not all charts
undergo physician review. However, our trigger
screening sensitivity analysis indicates that the adverse
event rate would only result in a relative 4% increase
(to 12.7%) if physicians had reviewed all charts.
Events detected in the index admission that occurred
over a year beforehand (estimated to contribute 10%
of all events3), and events from the index admission
that were detected after a year are not included. In
addition, retrospective chart review is restricted to
chart documentation without direct information from
staff involved in patient care. Our reviewers commen-
ted that there was significant variability across hospi-
tals in terms of filing practices, recording of
information (extent of documentation, handwritten or
typed), layout of drug charts, presence of discharge
summaries and availability of investigation results.
Furthermore, studies comparing prospective and
retrospective methodologies have found that although
these methods identify similar rates of events, they do
not necessarily identify the same adverse events.47
In addition, chart review relies on consistency
between reviewers, in order for physicians to agree
that an adverse event has occurred, all three elements
of the definition (injury, resulting disability at dis-
charge/prolonged hospitalisation/ death and causation)
must concur. Our κ statistic of 0.59 for physicians is
in line with other studies, where κs have ranged from
0.25 to 0.78.15 19 This need for reviewer consistency
across elements of the adverse event definition high-
lights the problem of rater reliability in detecting
adverse events. To enhance reviewer consistency,
INAES employed standardised training and structured
implicit review, with the data collection tool guiding
physicians to informed professional judgements.
Irish healthcare has undergone extensive change
due to the economic recession and the growth of the
quality movement, including the National Clinical
Programmes. Therefore, our study of adverse events
in 2009, near the start of these dual influences, pro-
vides an important baseline and the opportunity to
link safety with subsequent organisational reform.11
However, while our results describe the burden of
adverse events, the retrospective methodology may be
viewed as a blunt instrument for monitoring specific
quality initiatives, as adverse events are a heteroge-
neous group.48 A reduction in one category may be
counterbalanced by an increase in others, leading to
no overall change in adverse event rates. Thus, inter-
ventions to reduce adverse events need to be targeted
at specific adverse event categories, and studies moni-
toring effects tailored accordingly.41 48
The INAES web-based tool is now available for use
in Irish hospitals, providing an electronic application
for chart review that will allow hospitals to conduct
their own reviews and monitor patient-safety initia-
tives. The results from these reviews will be directly
comparable with the INAES results. Furthermore,
other national studies have spearheaded the develop-
ment of national patient-safety organisations and
policy, and we anticipate that this study will further
support patient-safety initiatives in the Irish healthcare
setting.1 12–14
CONCLUSION
INAES provides the first estimate of adverse event
occurrence within the Irish healthcare system and an
important measure of the burden and impact of these
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events. Our results give an overview of the types of
patient-safety issues that will help guide future inter-
ventions to reduce specific adverse events and
improve safety. We found a significant discrepancy
between our rate of adverse events and that reported
to the national reporting scheme. Therefore, efforts
must be made to encourage a ‘reporting culture’.
From an international perspective, this most recent
large-scale retrospective chart review national study
shows broad consistency yet again in the frequency
and nature of adverse events. Patient-safety experts
should question why, after 30 years, there has been so
little evidence of overall improvement.
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